Overview

Optimization of Postpartum Thromboprophylaxis

Status:
Active, not recruiting

Trial end date:
2022-06-22

Target enrollment:

Participant gender:

Summary

This is single centre pilot, randomized controlled trial assessing postpartum prophylactic anticoagulation with 3 weeks of LMWH followed by 3 weeks of Aspirin compared to standard of care of prophylactic LMWH for 6 weeks at moderate to high risk of developing VTE.

Phase:

N/A

Details

Lead Sponsor:

Mount Sinai Hospital, Canada

Treatments:

Aspirin
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin